Clinical Trial Update: Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating intravitreal ranibizumab injections to treat retinal tumors in patients with Von Hippel-Lindau disease; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Hippel-lindau Disease

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Von Hippel-Lindau Syndrome | Phase 1 | Status: COMPLETED